Johnson Matthey Valuation

Is JMPL.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of JMPL.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: JMPL.F ($19.84) is trading below our estimate of fair value ($26.78)

Significantly Below Fair Value: JMPL.F is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for JMPL.F?

Key metric: As JMPL.F is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for JMPL.F. This is calculated by dividing JMPL.F's market cap by their current earnings.
What is JMPL.F's PE Ratio?
PE Ratio23.9x
EarningsUK£108.00m
Market CapUK£2.58b

Price to Earnings Ratio vs Peers

How does JMPL.F's PE Ratio compare to its peers?

The above table shows the PE ratio for JMPL.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average25.4x
ASH Ashland
18.5x5.0%US$3.8b
SXT Sensient Technologies
37.2x20.2%US$3.4b
KWR Quaker Chemical
23x18.3%US$2.9b
FUL H.B. Fuller
22.9x14.1%US$4.3b
JMPL.F Johnson Matthey
23.9x28.5%US$2.6b

Price-To-Earnings vs Peers: JMPL.F is good value based on its Price-To-Earnings Ratio (23.9x) compared to the peer average (25.9x).


Price to Earnings Ratio vs Industry

How does JMPL.F's PE Ratio compare vs other companies in the US Chemicals Industry?

6 CompaniesPrice / EarningsEstimated GrowthMarket Cap
FFHL Fuwei Films (Holdings)
2.8xn/aUS$27.11m
BSLK Bolt Projects Holdings
0.07xn/aUS$10.99m
GSPI Green Star Products
1.5xn/aUS$1.49m
TANH Tantech Holdings
0.2xn/aUS$1.24m
JMPL.F 23.9xIndustry Avg. 23.3xNo. of Companies9PE01224364860+
6 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: JMPL.F is expensive based on its Price-To-Earnings Ratio (23.9x) compared to the US Chemicals industry average (23.3x).


Price to Earnings Ratio vs Fair Ratio

What is JMPL.F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

JMPL.F PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio23.9x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate JMPL.F's Price-To-Earnings Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst JMPL.F forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
US$24.44
0%
14.7%US$30.46US$20.74n/a11
Nov ’25US$18.85
US$24.44
+29.7%
14.7%US$30.46US$20.74n/a11
Oct ’25n/a
US$26.16
0%
13.3%US$30.77US$21.40n/a12
Sep ’25n/a
US$25.69
0%
12.9%US$30.90US$20.60n/a12
Aug ’25n/a
US$25.69
0%
12.9%US$30.90US$20.60n/a12
Jul ’25n/a
US$25.13
0%
14.1%US$30.34US$18.46n/a12
Jun ’25US$23.30
US$25.42
+9.1%
13.6%US$30.63US$18.64n/a12
May ’25US$21.75
US$24.40
+12.2%
12.7%US$28.41US$18.04n/a12
Apr ’25n/a
US$23.84
0%
15.8%US$29.03US$17.67n/a13
Mar ’25n/a
US$22.96
0%
14.4%US$29.02US$17.67n/a15
Feb ’25US$20.07
US$23.28
+16.0%
14.6%US$29.05US$17.68n/a16
Jan ’25n/a
US$23.45
0%
14.8%US$29.20US$17.77n/a16
Dec ’24US$19.94
US$23.45
+17.6%
14.8%US$29.20US$17.77n/a16
Nov ’24US$17.14
US$23.63
+37.9%
16.8%US$34.96US$17.03US$18.8516
Oct ’24US$20.01
US$24.89
+24.4%
16.1%US$34.95US$17.02n/a18
Sep ’24US$20.84
US$26.00
+24.8%
15.8%US$36.19US$17.62n/a18
Aug ’24n/a
US$27.51
0%
14.4%US$38.47US$20.87n/a17
Jul ’24US$22.55
US$26.71
+18.5%
13.6%US$37.52US$20.35n/a17
Jun ’24US$22.00
US$26.66
+21.2%
13.3%US$37.43US$19.85US$23.3017
May ’24n/a
US$27.29
0%
13.1%US$37.90US$20.11US$21.7517
Apr ’24US$24.43
US$27.52
+12.6%
12.3%US$37.21US$19.74n/a17
Mar ’24n/a
US$26.91
0%
13.8%US$38.84US$19.27n/a18
Feb ’24US$28.40
US$27.66
-2.6%
13.8%US$39.91US$19.80US$20.0718
Jan ’24n/a
US$27.45
0%
14.1%US$39.86US$19.77n/a18
Dec ’23n/a
US$26.99
0%
14.9%US$39.48US$19.59US$19.9418
Nov ’23n/a
US$24.85
0%
15.9%US$37.92US$18.05US$17.1418

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies